Published in Int J Mol Sci on November 08, 2016
Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer (2002) 34.99
Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol (2006) 8.52
Focal adhesion kinase: the first ten years. J Cell Sci (2003) 6.83
Sortilin is essential for proNGF-induced neuronal cell death. Nature (2004) 5.62
The influence of cell mechanics, cell-cell interactions, and proliferation on epithelial packing. Curr Biol (2007) 5.17
The sorting receptor for yeast vacuolar carboxypeptidase Y is encoded by the VPS10 gene. Cell (1994) 5.10
NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. J Biol Chem (2004) 4.37
Integrins. Cell Tissue Res (2009) 4.11
ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci (2005) 3.76
Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron (2010) 3.44
Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev (2003) 2.92
Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography. J Biol Chem (1997) 2.69
Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem (1999) 2.55
Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev (2010) 2.21
Are desmosomes more than tethers for intermediate filaments? Nat Rev Mol Cell Biol (2000) 2.20
VPS10P-domain receptors - regulators of neuronal viability and function. Nat Rev Neurosci (2008) 1.98
The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J Biol Chem (1998) 1.84
Neurotensin and neurotensin receptors. Trends Pharmacol Sci (1999) 1.71
The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin. EMBO J (2003) 1.58
Dynamic contacts: rearranging adherens junctions to drive epithelial remodelling. Nat Rev Mol Cell Biol (2014) 1.53
The Vps10p-domain receptor family. Cell Mol Life Sci (2009) 1.50
Cell-cell connectivity: desmosomes and disease. J Pathol (2011) 1.36
Desmosomes: new perpetrators in tumour suppression. Nat Rev Cancer (2011) 1.33
Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases. Am J Pathol (1991) 1.22
Fine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survival. PLoS One (2011) 1.20
GRK2: multiple roles beyond G protein-coupled receptor desensitization. Trends Pharmacol Sci (2012) 1.15
Tumour necrosis factor alpha-converting enzyme mediates ectodomain shedding of Vps10p-domain receptor family members. Biochem J (2006) 1.13
Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line. Gastroenterology (2002) 1.12
Ectodomain shedding, translocation and synthesis of SorLA are stimulated by its ligand head activator. J Cell Sci (2000) 1.11
Structural, biochemical and signaling properties of the low-density lipoprotein receptor gene family. Front Biosci (2001) 1.09
Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia. J Neurosci (2003) 1.08
Sorting receptor SORLA--a trafficking path to avoid Alzheimer disease. J Cell Sci (2013) 1.07
Nuclear FAK: a new mode of gene regulation from cellular adhesions. Mol Cells (2013) 1.06
Sortilin, SorCS1b, and SorLA Vps10p sorting receptors, are novel gamma-secretase substrates. Mol Neurodegener (2006) 1.05
Role of endogenous brain-derived neurotrophic factor and sortilin in B cell survival. J Immunol (2008) 1.05
Altered expression and function of beta1 integrins in a highly metastatic human lung adenocarcinoma cell line. Int J Oncol (2000) 1.04
ADAM-mediated amphiregulin shedding and EGFR transactivation. Cell Prolif (2009) 1.03
The regulation of cancer cell death and metabolism by extracellular matrix attachment. Semin Cell Dev Biol (2012) 1.01
Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung. J Clin Oncol (1998) 1.01
Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas. Genes Dis (2015) 0.99
Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors. J Cell Sci (2014) 0.99
Cancer, chemistry, and the cell: molecules that interact with the neurotensin receptors. ACS Chem Biol (2009) 0.97
Tumor-derived exosomes in cancer progression and treatment failure. Oncotarget (2015) 0.94
Neurotensin stimulates expression of early growth response gene-1 and EGF receptor through MAP kinase activation in human colonic epithelial cells. Int J Cancer (2007) 0.93
Sortilin turnover is mediated by ubiquitination. Biochem Biophys Res Commun (2013) 0.92
Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines. Int J Cancer (2001) 0.92
Shedding of the luminal domain of the neurotensin receptor-3/sortilin in the HT29 cell line. Biochem Biophys Res Commun (2002) 0.91
Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers. Int J Mol Sci (2015) 0.88
Adhesion complexes implicated in intestinal epithelial cell-matrix interactions. Microsc Res Tech (2000) 0.87
TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells. Oncotarget (2016) 0.85
ROCK1 and ROCK2 regulate epithelial polarisation and geometric cell shape. Biol Cell (2012) 0.85
Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib. Oncotarget (2014) 0.84
EGFR Transactivation by Peptide G Protein-Coupled Receptors in Cancer. Curr Drug Targets (2016) 0.83
Neurotensin receptor-2 and -3 are crucial for the anti-apoptotic effect of neurotensin on pancreatic beta-TC3 cells. Int J Biochem Cell Biol (2009) 0.83
Focal adhesion kinase dependent activation of the PI3 kinase pathway by the functional soluble form of neurotensin receptor-3 in HT29 cells. Int J Biochem Cell Biol (2013) 0.82
Increased serum levels of sortilin are associated with depression and correlated with BDNF and VEGF. Transl Psychiatry (2015) 0.82
Ca(2+)-mobilising agonists potentiate forskolin- and VIP-stimulated cAMP production in human colonic cell line, HT29-cl.19A: role of [Ca2+]i and protein kinase C. Cell Calcium (1994) 0.82
Phosphoinositide 3-kinases-a historical perspective. Subcell Biochem (2012) 0.80
How actin/myosin crosstalks guide the adhesion, locomotion and polarization of cells. Biochim Biophys Acta (2015) 0.80
Sortilin is associated with breast cancer aggressiveness and contributes to tumor cell adhesion and invasion. Oncotarget (2015) 0.80
Impairement of HT29 Cancer Cells Cohesion by the Soluble Form of Neurotensin Receptor-3. Genes Cancer (2014) 0.79
Neuropeptides as lung cancer growth factors. Peptides (2015) 0.77
Soluble sortilin is released by activated platelets and its circulating levels are associated with cardiovascular risk factors. Atherosclerosis (2016) 0.77
Effects of Statin Therapy on Plasma Proprotein Convertase Subtilisin/kexin Type 9 and Sortilin Levels in Statin-Naive Patients with Coronary Artery Disease. J Atheroscler Thromb (2016) 0.77
[Colorectal carcinoma--current pathogenetic concepts. Significance of cell-matrix interaction for invasive growth and metastasis]. Schweiz Rundsch Med Prax (1992) 0.76
Sortilin: A novel regulator in lipid metabolism and atherogenesis. Clin Chim Acta (2016) 0.76
Soluble sortilin is present in excess and positively correlates with progranulin in CSF of aging individuals. Exp Gerontol (2016) 0.76
A new role under sortilin's belt in cancer. Commun Integr Biol (2016) 0.76
Focal adhesion kinase-regulated signaling events in human cancer. Biomol Concepts (2012) 0.75
Sortilin, a novel APOE receptor implicated in Alzheimer disease. Prion (2013) 0.75